Nevertheless, we also identified that AKAP12 indicated better prognoses in KIRC, LAML, and THCA, this might be attributed to the difference in genetic heterogeneity and clinical features of different cancer types and subtypes (Meacham and Morrison, 2013). This evidence concerns the gene AKAP12 and cancer.